Related references
Note: Only part of the references are listed.Proteoglycans remodeling in cancer: Underlying molecular mechanisms
Achilleas D. Theocharis et al.
MATRIX BIOLOGY (2019)
Chondroitin sulfate-mediated N-cadherin/-catenin signaling is associated with basal-like breast cancer cell invasion
Satomi Nadanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Proteoglycans-Biomarkers and Targets in Cancer Therapy
Dragana Nikitovic et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
Celia S. L. Mak et al.
MOLECULAR CANCER (2017)
The role of miR-26a and miR-30b in HER2+breast cancer trastuzumab resistance and regulation of the CCNE2 gene
Eduardo Tormo et al.
SCIENTIFIC REPORTS (2017)
Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycans Are Targeted by Bleomycin in Cancer Cells
Xiulian Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Glycosaminoglycans from marine sources as therapeutic agents
Jesus Valcarcel et al.
BIOTECHNOLOGY ADVANCES (2017)
Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes
Bruna Corradetti et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2017)
Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells
Ana Paula de Sousa Mesquita et al.
APOPTOSIS (2017)
Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population
M. Rushton et al.
CURRENT ONCOLOGY (2017)
Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation
Nguyen Thi Bich Huyen et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2016)
Syndecan-4 Promotes Epithelial Tumor Cells Spreading and Regulates the Turnover of PKCα Activity under Mechanical Stimulation on the Elastomeric Substrates
Chun-Ping Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
miRNA-542-3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation
Tao Ma et al.
ONCOLOGY REPORTS (2015)
Extracellular Molecules Involved in Cancer Cell Invasion
Theodora Stivarou et al.
CANCERS (2015)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells
Bruna Ribeiro Carneiro et al.
PLOS ONE (2014)
Heparan sulfate mediates trastuzumab effect in breast cancer cells
Eloah Rabello Suarez et al.
BMC CANCER (2013)
The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma
Tracey Hurrell et al.
CANCER CELL INTERNATIONAL (2013)
Syndecan-4 signaling at a glance
Arye Elfenbein et al.
JOURNAL OF CELL SCIENCE (2013)
Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
Vassiliki T. Labropoulou et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Elimination of breast tumor-associated chondroitin sulfate promotes metastasis
R. D. Prinz et al.
GENETICS AND MOLECULAR RESEARCH (2011)
Overcoming anoikis - pathways to anchorage-independent growth in cancer
Marta C. Guadamillas et al.
JOURNAL OF CELL SCIENCE (2011)
Extracellular Matrix Degradation and Remodeling in Development and Disease
Pengfei Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A. Cooney et al.
BREAST CANCER RESEARCH (2011)
Primary trastuzumab resistance: new tricks for an old drug
Jason A. Wilken et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
The extracellular matrix at a glance
Christian Frantz et al.
JOURNAL OF CELL SCIENCE (2010)
Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft
Anli Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2010)
MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
Shawn P. Fessler et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Jason J. Zoeller et al.
MATRIX BIOLOGY (2009)
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Hannu Jarvelainen et al.
PHARMACOLOGICAL REVIEWS (2009)
Anoikis resistance and tumor metastasis
Craig D. Simpson et al.
CANCER LETTERS (2008)
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
G. Valabrega et al.
ANNALS OF ONCOLOGY (2007)
EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase
C. C. Lopes et al.
BIOCHIMIE (2006)
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype
Fusun Baba et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Syndecans: Proteoglycan regulators of cell-surface microdomains?
JR Couchman
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Analysis of glycosaminoglycan-derived disaccharides in biologic: samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans
FN Lamari et al.
BIOMEDICAL CHROMATOGRAPHY (2002)
Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans
DF Liu et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Share Paper
